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Abstract
Curative resection remains the only hope of cure for hepatocellular carcinoma (HCC), but postoperative complications can have a
significant impact on long-term survival. However, only scarce data on such impact can be found in the literature.
This retrospective study reviewed the prospectively collected data of patients who underwent primary liver resection for HCC at our
hospital during the period from December 1989 to December 2014. Patients with and without postoperative complications were
compared. A 1:1 propensity score matching was adopted by matching age, comorbidity, Model of End-stage Liver Disease score,
tumor stage, and extent of resection.
Totally 1710 patients were eligible for the study. Four hundred and sixty-one (27.0%) of them developed postoperative
complications while 1249 (73.0%) did not. After propensity score matching, 922 patients were compared in a 1:1 ratio (461 with
postoperative complications and 461 without). Patients who developed postoperative complications were demographically similar
to patients who did not, but had more intraoperative blood loss and transfusion (both P<0.001), longer hospital stay (17 vs 9 days;
P<0.001), worse hospital mortality (12.1% vs 0%; P<0.001), and shorter overall survival (P<0.001). On multivariate analysis,
factors that might have affected overall survival were cancer stage (HR 1.22, P<0.001), tumor size (HR 1.02, P=0.005), tumor
number (HR 1.08, P<0.001), venous invasion (HR 1.38, P=0.003), extent of resection (HR 1.19, P=0.045), intraoperative blood
loss (HR 1.11, P<0.001), postoperative complication (HR 1.37, P<0.001), and era effect (HR 1.27, P=0.01).
Patients should be monitored closely after HCC resection. Prompt treatment of postoperative complications may be salvational.
Abbreviations: HCC = hepatocellular carcinoma, ICG = indocyanine green, PSM = propensity score matching.
Keywords: complications, hepatectomy, hepatocellular carcinoma, liver resection, survival
1. Introduction
Hepatocellular carcinoma (HCC) is the most common primary
liver cancer, with a high prevalence in Asia and an increasing
incidence in Western countries.[1] It is the 3rd most common
cancer causing deaths in Hong Kong.[2] The resectability rate for
HCC is only 20%, and hence its prognosis is generally poor.[3,4]
Postoperative complications may have adverse effects on the
long-term outcomes of surgeries.[5,6] Studies of colorectal surgery
have suggested that postoperative anastomotic leakage increases
the likelihood of tumor recurrence and threatens long-term
patient survival after colorectal resection.[5,6] Highmorbidity and
high mortality are often seen after liver resection for HCC with
background cirrhosis.[7] This study was to determine the impact
of postoperative complication on the survival outcomes of
curative resection for HCC.
2. Methods
This retrospective study reviewed the prospectively collected data
of patients who underwent primary liver resection for HCC at
our hospital during the period fromDecember 1989 to December
2014. All operations were standardized and were operated by
the same team of surgeons. This study did not require specific
institutional approval since our institution permits the use of
clinical data in retrospective studies provided that no patient can
be identified.
2.1. Diagnosis and perioperative management
Diagnosis of HCC was based on the typical imaging finding (ie,
early arterial enhancement with early portovenous washout) on
computed tomography or magnetic resonance imaging and/or a
serum a-fetoprotein level >400ng/mL; results of HBsAg and
anti-HCV tests were also taken into account. Adequate hepatic
functional reserve and absence of extrahepatic disease were
prerequisites for liver resection. Moreover, the tumor had to be
anatomically resectable as evaluated by imaging studies. Hepatic
function assessment was by Child–Pugh classification[8] or
indocyanine green (ICG) clearance test. From 1989 to 1994,
the decision for a hepatectomy was based mainly on Child–Pugh
classification. Child–Pugh class C was regarded as a contra-
indication. After the ICG retention safety limit for major
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hepatectomy was determined in 1995,[9] suitability for hepatec-
tomy was based largely on ICG clearance test result rather than
Child–Pugh class. Patients with an ICG retention rate 14% at
15minutes were eligible for major hepatectomy.[10] Our liver
resection technique and postoperative management protocol
have been described in previous reports.[3,11] Patients were
encouraged to mobilize as early as possible after operation.
Diagnosis of recurrence was based on the typical imaging finding;
percutaneous fine-needle aspiration cytology was also conducted
if radiological results were doubtful. Since 2010, dual-tracer
positron emission tomography was performed when indefinite
recurrences were encountered.[12] A standardized aggressive
management protocol as described in a previous report was
adopted to treat recurrences.[13]
2.2. Statistical analysis
Resection of ≥3 liver segments (according to the Couinaud
classification) was regarded as a major resection; otherwise it was
a minor resection. Hospital death was death occurring during the
hospital stay for the primary operation or within 30 days of the
operation. Postoperative complication was defined as any
deviation from the normal postoperative course with the need
for pharmacological, surgical, endoscopic or radiological
intervention, and all postoperative complications were graded
according to the Clavien–Dindo classification.[14] Pearson chi-
squared test was used to compare categorical variables. Student t
test and the Mann–Whitney U test were used to compare
continuous variables. The Kaplan–Meier method was used in
survival analyses, and the log-rank test was used for survival
comparison. P<0.05 denoted statistical significance, and all
P values were 2-tailed. A 1:1 propensity score matching (PSM)
was performed by matching age (P=0.778), comorbidity
(P=0.895), Model of End-stage Liver Disease score (P=
0.394), tumor stage (according to the International Union
Against Cancer tumor-node-metastasis staging system, 7th
edition) (P=0.320), and extent of resection (major versus minor)
(P=0.830) with the nearest neighbor procedure by the software
R (version 3.2.0 [2015-04-16]). Other analyses were performed
by the computer software SPSS, version 18.
3. Results
A total of 1710 patients were eligible for the study. Four hundred
and sixty-one (27.0%) of them developed postoperative
complications while 1249 (73.0%) did not. After PSM, 922
patients were compared in a 1:1 ratio (461 with postoperative
complications and 461 without). Table 1 is a comparison of
preoperative and operative characteristics between patients with
and without postoperative complications, and Table 2 is a
comparison of pathological data of the 2 groups of patients. The
types and incidences of postoperative complications are shown in
Table 3. The study period, which spanned 26 years, was divided
into 2 halves – period 1 (1989–2001) and period 2 (2002–2014) –
which were then compared. Period 2 saw significant improve-
ments in 4 respects, which can be viewed in Table 4.
Patients with and without postoperative complications had
significantly different overall survival (Fig. 1A) and disease-free
survival (Fig. 1B). Table 5 shows the univariate and multivariate
analyses of factors that might have affected overall survival.
Among the factors was postoperative complication. The impact
of different types of postoperative complication on overall
survival is shown in Table 6. Overall survival in period 2 was
better than that in period 1 (Table 5).
Table 1
Preoperative and operative characteristics of patients with and without postoperative complications.
No complication (n=461) With complication (n=461) P
∗
Sex ratio (male:female) 376:85 385:76 0.435
Age, years† 60 (18–84)‡ 59 (18–86)‡ 0.778
Hepatitis B virus infection 379 (82.2%) 374 (81.1%) 0.103
Hepatitis C virus infection 18 (3.9%) 19 (4.1%) 0.481
Presence of comorbidity 203 (44%) 205 (44.5%) 0.895
Child–Pugh class 0.009
A 445 (96.5%) 427 (92.6%)
B 16 (3.5%) 34 (7.4%)
Serum a-fetoprotein, ng/mLx 130 (1–1112000)jj 91 (1–1335900)jj 0.935
Indocyanine green retention rate at 15 min† 11.1 (1.3–66.9)‡ 11.1 (1.6–69.3)‡ 0.209
Tumor size, cmx 7 (0.7–22)jj 6.5 (0.7–28)jj 0.932
Number of tumor nodule 0.516
Solitary 320 (69.4%) 329 (71.4%)
Multiple 141 (30.6%) 132 (28.6%)
Extent of resection 0.830
Major 322 (69.8%) 319 (69.2%)
Minor 139 (30.2%) 142 (30.8%)
Intraoperative blood loss, Lx 0.8 (0.02–13)jj 1.3 (0.05–20)jj <0.001¶
Intraoperative blood transfusion, Lx 0 (0–5.7)jj 0 (0–9.6)jj <0.001¶
Hospital death 0 56 (12.1%) <0.001¶
Hospital stay, daysx 9 (3–77)jj 17 (1–198)jj <0.001¶
∗
Pearson chi-squared test unless otherwise indicated.
† Student t test.
‡Mean value (standard deviation).
x The Mann–Whitney U test.
jjMedian value (range).
¶ Statistically significant.
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4. Discussion
With advances in surgical skills and perioperative care, the
mortality rate after major hepatectomy has decreased from
58%[6] to <10%.[15] Although primary liver transplantation is
another option for curing HCC within criteria, the shortage of
grafts limits its applicability. Liver resection is still considered to
be the 1st-line treatment, especially for patients with relatively
preserved liver function.
Certain factors have been found to affect overall survival after
major hepatectomy, which include tumor stage, tumor biology,
and postoperation complication. The 1 factor that can be altered
by clinicians is postoperative complication. A number of studies
have demonstrated the impact of postoperative complication on
survival, but the classification of complications differed in them; a
couple of them did not use the Clavien–Dindo classification.[16,17]
In the study by Kusano et al,[18] which analyzed the postoperative
course of 291 patients, the presence of postoperative complica-
tion was identified on multivariate analysis as one of the
significant factors that affected overall survival. In the study by
Okamura et al,[19] this factor was also identified on univariate
analysis, though not on multivariate analysis.
The relationship between postoperative complication and
survival is a complicated one. Different mechanisms causing such
a relationship have been posited. Farid et al[20] saw a survival
disadvantage after liver resection for colorectal liver metastasis in
patients with complications, and postoperative sepsis was found
to be one of the independent factors associated with overall
survival and disease-free survival on multivariate analysis. They
looked into the septic complications and found that intra-
abdominal and respiratory infections were associated with
poorer long-term outcomes whereas wound infections were
not. So far the only kind of postoperative complications whose
mechanism is better understood is septic complications. Evidence
from studies of other malignancies like colorectal cancer has
shown that proinflammatory cytokines such as TNFa and IL-1b
increase tumor cell adhesion to endothelial cells in vitro and in
vivo by upregulating the expression of cell adhesion
molecules.[21–23] Most posited mechanisms are about how
infective complications affect oncological outcomes. As for
cardiac or renal complications, they may be confounding factors
in the prediction of overall survival; further studies are needed
before a definitive answer can be given.
Besides careful preoperative assessment and patient selection,
intraoperative blood loss should be minimized. The likelihood of
postoperative complication seems to correlate with the amounts
of intraoperative blood loss and transfusion, as shown in this
Table 2
Pathological data of patients with and without postoperative
complications.
No complication
(n=461)
With complication
(n=461) P
∗
Nontumorous liver† 0.113
No cirrhosis 74 (161%) 56 (12.1%)
Chronic hepatitis 137 (29.7%) 127 (27.5%)
Cirrhosis 250 (54.2%) 278 (60.3%)
Tumor–node–metastasis stage‡ 0.32
I 158 (34.3%) 161 (34.9%)
II 128 (27.8%) 135 (29.3%)
IIIA 70 (15.2%) 52 (11.3%)
IIIB 41 (8.9%) 39 (8.5%)
IIIC 63 (13.7%) 69 (15%)
IVA 1 (0.2%) 5 (1.1%)
Presence of venous invasion 247 (53.6%) 244 (52.9%) 0.843
Degree of differentiationx 0.385
Well 85 (18.4%) 95 (20.6%)
Moderate 255 (55.3%) 253 (54.9%)
Poor 110 (23.9%) 93 (20.2%)
Undifferentiated 3 (0.7%) 4 (0.9%)
Necrosis 0 1 (0.2%)
Data of some patients are unavailable.
∗
Pearson chi-squared test.
† By histology.
‡ International Union Against Cancer tumor–node–metastasis staging system, 7th edition.
x New Edmondson grading.
Table 3
Types and incidences of postoperative complications.
No. of patients
Cardiac complications
a. Myocardial infarction 3 (0.3%)
b. Cardiac arrhythmia 61 (6.6%)
c. Heart failure 5 (0.5%)
With 1 or more of the above 66 (7.2%)
Pulmonary complications
a. Chest infection 82 (8.9%)
b. Chest infection requiring bronchoscopy 23 (2.5%)
c. Chest infection requiring tracheostomy 14 (1.5%)
d. Pleural effusion with tapping 73 (7.9%)
e. Pleural effusion without tapping 180 (19.5%)
f. Empyema thoracis 1 (0.1%)
g. Pulmonary embolism 3 (0.3%)
h. Pneumothorax 21 (2.3%)
With 1 or more of the above 302 (32.8%)
With 1 or more of b, c, or d 96 (10.4%)
Wound complications 98 (10.6%)
Wound infection 86 (9.3%)
Wound dehiscence 16 (1.7%)
Bleeding
Intraabdomen bleeding 30 (3.3%)
Peptic ulcer bleeding 12 (1.3%)
Variceal bleeding 2 (0.2%)
Intraabdominal infection
Infected ascites 6 (0.7%)
Subphrenic abscess 22 (2.4%)
Urinary tract infection 4 (0.4%)
Biliary fistula or leakage 27 (2.9%)
Ileus or intestinal obstruction 6 (0.7%)
Liver failure 55 (6%)
Renal failure 51 (5.5%)
Table 4
Comparison of short-term outcomes in the 2 periods.
1989–2001
(n=369)
2002–2014
(n=553) P
∗
Intraoperative blood loss, L 1.5 (0.05–20)† 0.8 (0.02–14)† <0.001‡
Intraoperative blood transfusion, L 0 (0–9.6)† 0 (0–7.7)† <0.001‡
Hospital death 33 (8.9%) 23 (2%) 0.003x
Postoperative complication <0.001x
No 152 (41.2%) 878 (78.3%)
Yes 217 (58.8%) 244 (21.7%)
∗
All statistically significant.
†Median (range).
‡ The Mann–Whitney U test.
x Pearson chi-squared test.
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study as well as previous studies.[24,25] Intraoperative blood loss
and postoperative complication have been shown to be
associated with overall survival and disease-free survival.[26]
Ways of reducing blood loss include maintaining a low central
venous pressure and selective use of the Pringle maneuver. Blood
transfusion should be avoided as far as possible as it may
contribute to an immunocompromised state and affect long-term
oncological outcomes.[27] At our center, permissive anemia in
asymptomatic patients is allowed and blood transfusion is
perioperatively avoided as far as possible. The use of ultrasonic
dissector for liver resection has been shown to reduce blood loss
and morbidity.[28] On the other hand, a Japanese group showed
that the clamp-crush technique produced similar results.[29]
Other advanced energy sources may also help to reduce
intraoperative blood loss, but proper randomized controlled
trials are required to confirm their effectiveness. However, the
results of any transection technique are likely affected by the
experience and expertise of the handling surgeons and centers.
Among all reported studies of the relationship between
postoperative complications and survival outcomes of HCC
resection, the present study is the first one to employ PSM. With
this method, the impact of selection bias in the estimation of
causal effects in observational studies can be reduced. By
conditioning on the propensity score, some of the characteristics
of a randomized controlled trial can be replicated. A randomized
controlled trial, if carried out appropriately, can balance out both
measured and unmeasured baseline variables. With PSM, only
the distribution of certain selected measured baseline variables
Figure 1. (A) Overall survival of patients with and without postoperative complications. (B) Disease-free survival of patients with and without postoperative
complications.
Table 5
Univariate and multivariate analyses of factors that might have affected overall survival.
Univariate analysis Multivariate analysis
HR (95% CI) P
∗
HR (95% CI) P
∗,†
Age 0.475
70 years 1 – –
>70 years 1.1 (0.85–1.41)
Cancer stage‡ 1.37 (1.3–1.45) <0.001 1.22 (1.13–1.31) <0.001
Child–Pugh class 0.242
A 1 – –
B 1.25 (0.86–1.8)
Presence of venous invasion 1.99 (1.67–2.37) <0.001 1.38 (1.12–1.71) 0.003
Extent of resection <0.001 0.045
Major 1.44 (1.19–1.75) 1
Minor 1 1.19 (1.004–1.41)
Intraoperative blood loss 1.14 (1.11–1.18) <0.001 1.11 (1.06–1.16) <0.001
Tumor size 1.06 (1.04–1.07) <0.001 1.02 (1.01–1.04) 0.005
Number of tumor nodule 1.12 (1.09–1.15) <0.001 1.08 (1.03–1.13) <0.001
Presence of postoperative complication 1.46 (1.23–1.73) <0.001 1.37 (1.18–1.58) 0.001
Period 0.006 0.01
1989–2001 1 1.27 (1.06–1.53)
2002–2014 0.78 (0.65–0.93) 1
Factors with a P-value 0.1 on univariate analysis were put into the multivariate model selection. CI=confidence interval, HR=hazards ratio.
∗
Cox proportional hazards model.
† All statistically significant.
‡ International Union Against Cancer tumor–node–metastasis staging system, 7th edition.
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between 2 groups in an observational study can be balanced.
Therefore, there can still be unbalanced baseline characteristics
which are not measured. Nevertheless, since a randomized
controlled trial on the topic would be impractical, using PSM is
probably the closest method.
This study has limitations other than its retrospective nature.
The study spanned 26 years, during which surgical techniques
and perioperative care have much improved, and morbidity and
mortality have thus significantly reduced, as can be seen in
Table 4. This complicated the interpretation of the results.
Furthermore, all operations were performed by the same team of
surgeons at a single center. Although standardization in patient
care and surgical technique can be assured, whether the same
outcomes can be replicated elsewhere is unknown.
In conclusion, while there are factors which surgeons have no
control of (eg, cancer stage, tumor size and number, and presence
of venous invasion), every surgeon should do their best to
minimize intraoperative blood loss, and meticulous perioperative
care should be given to every patient to prevent postoperative
complications, which can significantly affect survival. Should any
postoperative complication develops, prompt treatment should
be given. Although the exact relationship between postoperative
complication and oncological outcome has not been established,
there is emerging evidence showing that postoperative morbidity
shortens disease-free survival. It is hoped that further research
will bring about further reduction in postoperative morbidity and
introduce more effective adjuvant treatments for postoperative
complications.
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